{"id":59627,"date":"2026-06-04T22:43:27","date_gmt":"2026-06-04T13:43:27","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4891\/"},"modified":"2026-08-23T13:58:56","modified_gmt":"2026-08-23T04:58:56","slug":"company-4891","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4891\/","title":{"rendered":"TMS CO LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4891","DATE":"2026-01-09","longName":"TMS Co., Ltd.","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"https:\/\/www.tms-japan.co.jp","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":143,"financialCurrency":"","marketCap":6504,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":-907791000,"operatingMargins":0,"NetIncome":-660548000,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-23.460000000000001,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":620,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T03:56:14.229918\", \"ticker\": \"4891\", \"ticker_full\": \"4891.T\", \"company_name\": \"TMS CO LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"0\", \"strong_buy\": 0, \"buy\": 1, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 98.0, \"high\": 620.0, \"low\": 620.0, \"mean\": 620.0, \"median\": 620.0}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 9.44, \"institution_pct\": 21.45, \"major_holders\": [{\"label\": \"\", \"value\": 9.44}, {\"label\": \"\", \"value\": 21.45}, {\"label\": \"\", \"value\": 23.68}, {\"label\": \"\", \"value\": 4.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory\/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory\/antioxidative activities under nonclinical development for inflammatory complications, such as acute kidney injury and cancer cachexia. It is also developing TMS-009, a product candidate in preclinical development. In addition, the company has a collaboration with Hokkaido University to evaluate the potential of the drug candidate compounds as novel drugs. TMS Co., Ltd. was incorporated in 2005 and is headquartered in Fuchu, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:02:17.746416\", \"ticker\": \"4891\", \"ticker_full\": \"4891.T\", \"company_name\": \"TMS CO LTD\", \"company_info\": {\"name_en\": \"TMS CO LTD\", \"long_name\": \"TMS Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.tms-japan.co.jp\", \"employees\": null, \"country\": \"Japan\", \"city\": \"Fuchu\", \"address\": \"1-9-11F, Fuchu-cho\", \"description\": \"TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory\/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory\/antioxidative activities under nonclinical development for inflammatory complications, such as acute kidney injury and cancer cachexia. It is also developing TMS-009, a product candidate in preclinical development. In addition, the company has a collaboration with Hokkaido University to evaluate the potential of the drug candidate compounds as novel drugs. TMS Co., Ltd. was incorporated in 2005 and is headquartered in Fuchu, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 109.8, \"deviation\": 0.18, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 100.8, \"deviation\": 9.13, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 114.24, \"deviation\": -3.71, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 131.57, \"deviation\": -16.39, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -907791000.0, \"operating_income_fmt\": \"-\u00a59\u5104\", \"ebit\": -907791000.0, \"ebit_fmt\": \"-\u00a59\u5104\", \"net_income\": -660548000.0, \"net_income_fmt\": \"-\u00a57\u5104\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 3032269000.0, \"total_assets_fmt\": \"\u00a530\u5104\", \"total_equity\": 2815488000.0, \"total_equity_fmt\": \"\u00a528\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2922950000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 92.85, \"de_ratio\": 0.0, \"current_ratio\": 13.97, \"operating_cf\": -493756000.0, \"operating_cf_fmt\": \"-\u00a55\u5104\", \"investing_cf\": -30843000.0, \"investing_cf_fmt\": \"-\u00a530.8M\", \"financing_cf\": 919000.0, \"financing_cf_fmt\": \"\u00a5919,000\", \"free_cf\": -524599000.0, \"free_cf_fmt\": \"-\u00a55\u5104\", \"net_margin\": 0, \"roe\": -23.46, \"roa\": -21.78}, {\"year\": 2024, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -943253000.0, \"operating_income_fmt\": \"-\u00a59\u5104\", \"ebit\": -943253000.0, \"ebit_fmt\": \"-\u00a59\u5104\", \"net_income\": -960040000.0, \"net_income_fmt\": \"-\u00a510\u5104\", \"eps\": -26.02, \"operating_margin\": 0, \"total_assets\": 3554754000.0, \"total_assets_fmt\": \"\u00a536\u5104\", \"total_equity\": 3457064000.0, \"total_equity_fmt\": \"\u00a535\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3446630000.0, \"total_cash_fmt\": \"\u00a534\u5104\", \"equity_ratio\": 97.25, \"de_ratio\": 0.0, \"current_ratio\": 36.36, \"operating_cf\": -822814000.0, \"operating_cf_fmt\": \"-\u00a58\u5104\", \"investing_cf\": -3356000.0, \"investing_cf_fmt\": \"-\u00a53.4M\", \"financing_cf\": 688133000.0, \"financing_cf_fmt\": \"\u00a57\u5104\", \"free_cf\": -826170000.0, \"free_cf_fmt\": \"-\u00a58\u5104\", \"net_margin\": 0, \"roe\": -27.77, \"roa\": -27.01}, {\"year\": 2023, \"revenue\": 0.0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": -520149000.0, \"operating_income_fmt\": \"-\u00a55\u5104\", \"ebit\": -520149000.0, \"ebit_fmt\": \"-\u00a55\u5104\", \"net_income\": -860925000.0, \"net_income_fmt\": \"-\u00a59\u5104\", \"eps\": -25.28, \"operating_margin\": 0, \"total_assets\": 3790215000.0, \"total_assets_fmt\": \"\u00a538\u5104\", \"total_equity\": 3714053000.0, \"total_equity_fmt\": \"\u00a537\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 3584667000.0, \"total_cash_fmt\": \"\u00a536\u5104\", \"equity_ratio\": 97.99, \"de_ratio\": 0.0, \"current_ratio\": 49.46, \"operating_cf\": -688423000.0, \"operating_cf_fmt\": \"-\u00a57\u5104\", \"investing_cf\": -13721000.0, \"investing_cf_fmt\": \"-\u00a513.7M\", \"financing_cf\": 1688809000.0, \"financing_cf_fmt\": \"\u00a517\u5104\", \"free_cf\": -702144000.0, \"free_cf_fmt\": \"-\u00a57\u5104\", \"net_margin\": 0, \"roe\": -23.18, \"roa\": -22.71}, {\"year\": 2022, \"revenue\": 1946520000.0, \"revenue_fmt\": \"\u00a519\u5104\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 1135636000.0, \"operating_income_fmt\": \"\u00a511\u5104\", \"ebit\": 1135636000.0, \"ebit_fmt\": \"\u00a511\u5104\", \"net_income\": 1076859000.0, \"net_income_fmt\": \"\u00a511\u5104\", \"eps\": 53.36, \"operating_margin\": 58.34, \"total_assets\": 2739781000.0, \"total_assets_fmt\": \"\u00a527\u5104\", \"total_equity\": 2453001000.0, \"total_equity_fmt\": \"\u00a525\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2598002000.0, \"total_cash_fmt\": \"\u00a526\u5104\", \"equity_ratio\": 89.53, \"de_ratio\": 0.0, \"current_ratio\": 9.54, \"operating_cf\": 1261786000.0, \"operating_cf_fmt\": \"\u00a513\u5104\", \"investing_cf\": -16958000.0, \"investing_cf_fmt\": \"-\u00a517.0M\", \"financing_cf\": 246482000.0, \"financing_cf_fmt\": \"\u00a52\u5104\", \"free_cf\": 1252898000.0, \"free_cf_fmt\": \"\u00a513\u5104\", \"net_margin\": 55.32, \"roe\": 43.9, \"roa\": 39.3}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-59627","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TMS CO LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4891\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4891\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4891\/\",\"name\":\"TMS CO LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:43:27+00:00\",\"dateModified\":\"2026-08-23T04:58:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4891\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4891\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4891\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TMS CO LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TMS CO LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4891\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4891\/","url":"https:\/\/japanir.jp\/en\/company\/company-4891\/","name":"TMS CO LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:43:27+00:00","dateModified":"2026-08-23T04:58:56+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4891\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4891\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4891\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"TMS CO LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/59627","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=59627"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=59627"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}